Meltwind Advisory LLP is the due diligence and portfolio management team for Jonathan Milner, founder and former CEO of Abcam. The firm invests in early-stage healthcare and biotech companies, focusing on life science tools, platform therapeutics, and drug discovery.
40% of their portfolio is in Biotech & Life Sciences.
Portfolio
5
Fund Size
—
Top Stage
Unknown
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EEnhanced Genomics | Series A | — | Sep 2025 |
 NanoSyrinx | Unknown | $12.7M | Sep 2024 |
 Kuano | Seed | — | Sep 2023 |
| SSanome | Unknown | — | Sep 2021 |
 clock.bio | Seed | $5.3M | — |
Top Co-Investors
BGF2 shared
Parkwalk Advisors1 shared
Octopus Ventures1 shared
IQ Capital1 shared
M Ventures1 shared
Eli Lilly and Company1 shared
firstminute capital1 shared
BlueYard Capital1 shared
Ascension Ventures1 shared
Mercia Asset Management1 shared
ACF Investors1 shared
Crista Galli Ventures1 shared
Omron1 shared
Last updated: 8 September 2026